清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Clinicopathological characteristics and response to neoadjuvant chemotherapy in HER2-low hormone receptor-positive breast cancer: a retrospective cohort study

医学 回顾性队列研究 乳腺癌 内科学 置信区间 化疗 肿瘤科 病态的 优势比 癌症 逻辑回归 子群分析 激素疗法 阶段(地层学) 激素疗法 队列研究 新辅助治疗 激素受体 激素 胃肠病学 队列 疾病 比例危险模型 危险系数 病例对照研究
作者
Wanyan Wu,Xuetao Li,Yanan Wei,Tiantian Liu,Ziwei Yang,Xiuli Liu
出处
期刊:Frontiers in Oncology [Frontiers Media]
卷期号:16
标识
DOI:10.3389/fonc.2026.1862110
摘要

Background HER2-low breast cancer constitutes a substantial proportion of hormone receptor-positive (HR+) cases, yet its biological behavior and responsiveness to neoadjuvant chemotherapy (NACT) remain incompletely characterized. This study aimed to compare clinicopathological features and pathological complete response (pCR) rates between HER2-low and HER2-zero expression in HR+ breast cancer patients receiving NACT. Materials and methods This retrospective cohort study included 178 HR+/HER2-negative breast cancer patients who received NACT followed by surgery at Yichang Central People’s Hospital between January 2020 and December 2024. Patients were categorized into HER2-low (immunohistochemistry [IHC] 1+ or 2+/ in situ hybridization [ISH]-, n=102) and HER2-zero (IHC 0, n=76) groups. Clinicopathological characteristics, pCR rates, residual cancer burden (RCB), Ki-67 changes, and treatment responses were compared. The primary outcome was total pathological complete response (tpCR, ypT0/is ypN0). Multivariable logistic regression and subgroup analyses were performed. Results The HER2-low group exhibited significantly higher proportions of Ki-67 index ≥20% (57.8% vs. 38.2%, P = 0.01) and grade III histology (45.1% vs. 28.9%, P = 0.03) compared to the HER2-zero group. The tpCR rate was significantly lower in the HER2-low group than in the HER2-zero group (11.8% vs. 25.0%, P = 0.02). Multivariable analysis identified HER2-low status as an independent negative predictor of tpCR (odds ratio [OR]=0.40, 95% confidence interval [CI]: 0.18-0.89, P = 0.02). The HER2-low group showed significantly smaller median Ki-67 reduction (-14.5% vs. -23.8%, P = 0.02). Subgroup analyses revealed that the negative impact of HER2-low status on pCR was more pronounced in patients with Ki-67 ≥20% (interaction P = 0.03) and grade III disease (interaction P = 0.04). Conclusions In this retrospective cohort of HR+ breast cancer patients, HER2-low expression was associated with more aggressive clinicopathological features and a significantly lower pCR rate compared to HER2-zero expression. After multivariable adjustment, HER2-low status remained significantly associated with reduced pCR odds (OR = 0.40, 95% CI: 0.18-0.89). These findings suggest that HER2-low may represent a clinically relevant subgroup within HR+ breast cancer, but the observational design precludes causal interpretation, and these hypothesis-generating results require validation in prospective, adequately powered studies before any clinical treatment recommendations can be made.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
DH完成签到 ,获得积分10
3秒前
naczx完成签到,获得积分0
5秒前
ay完成签到,获得积分20
8秒前
飞快的蛋的应助被ay采纳,获得30
16秒前
19秒前
朴素的荧荧完成签到,获得积分10
23秒前
愉快的书桃完成签到,获得积分10
47秒前
加油完成签到 ,获得积分10
58秒前
pigff完成签到,获得积分10
58秒前
系统昵称完成签到,获得积分10
1分钟前
白白完成签到,获得积分10
1分钟前
黑大侠完成签到 ,获得积分0
1分钟前
如意大神完成签到,获得积分10
1分钟前
武安发布了新的文献求助10
1分钟前
波波波波波6764完成签到 ,获得积分10
1分钟前
欢呼的听枫完成签到,获得积分10
1分钟前
狞风妖完成签到 ,获得积分10
1分钟前
syvshc的应助被科研通管家采纳,获得10
2分钟前
俭朴竺完成签到,获得积分10
2分钟前
超男完成签到 ,获得积分10
2分钟前
丰富凌晴完成签到,获得积分10
2分钟前
Ahui完成签到 ,获得积分10
2分钟前
优雅的梦芝完成签到,获得积分10
3分钟前
温柔的谷冬完成签到,获得积分10
3分钟前
3分钟前
ww发布了新的文献求助10
3分钟前
小伟跑位完成签到,获得积分10
4分钟前
满意的平凡完成签到,获得积分10
4分钟前
奥丁不言语完成签到 ,获得积分10
4分钟前
哈哈哈哈哈完成签到,获得积分10
4分钟前
n01W97的应助被科研通管家采纳,获得20
4分钟前
n01W97的应助被科研通管家采纳,获得20
4分钟前
4分钟前
勤奋笙的应助被科研通管家采纳,获得10
4分钟前
幽默绝悟完成签到,获得积分10
4分钟前
北鲲居士完成签到,获得积分10
4分钟前
qianci2009完成签到,获得积分0
4分钟前
甜蜜的紫菜完成签到,获得积分10
4分钟前
舒心的瑾瑜完成签到,获得积分10
4分钟前
失眠紫完成签到,获得积分10
5分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8185453
求助须知:如何正确求助?哪些是违规求助? 9574168
关于积分的说明 21834496
捐赠科研通 7783067
什么是DOI,文献DOI怎么找? 3434570
关于科研通互助平台的介绍 2558912
邀请新用户注册赠送积分活动 2481326